logo
logo

Foresite Capital Raises $969 Million to Invest in Early to Late-Stage Companies Transforming Healthcare

Feb 25, 2021•over 4 years ago

Amount Raised

$969 Million

San Francisco

Description

Foresite Capital, a multi-stage healthcare and life sciences investment firm, today announced it has closed its fifth and largest fundraise with $969 million in capital commitments, significantly oversubscribed above its original target. The offering comprises Foresite Capital Fund V, L.P. and Foresite Capital Opportunity Fund V, L.P. With these new funds, Foresite Capital is investing in emerging healthcare and life sciences companies at all stages that are solving some of the biggest inefficiencies and pain points of the $10 trillion global healthcare market

Company Information

Company

Foresite Capital

Location

San Francisco, California, United States

About

Foresite Capital is a multi-stage healthcare and life sciences investment firm with approximately $4 billion in assets under management. The firm aims to address areas of great unmet need by funding promising healthcare and life sciences businesses at all stages of their life cycles. Foresite Capital uses a data science-driven approach to invest in companies that leverage biology and big data to transform healthcare. Founded in 2011, Foresite Capital is based in the San Francisco Bay Area and New York City. For more information, please visit www.foresitecapital.com.

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Related People